Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Coherus Oncology, Inc. | 68,697 | reported | 01 Feb 2021 | tx 83+967,526−253,111 |
| CORGENTECH INC | 50,000 | reported | 03 Dec 2008 | tx 2+85,000 |
| SpyGlass Pharma, Inc. | 17,500 | reported | 05 Feb 2026 | tx 1+17,500 |
| VAXGEN INC | 4,648 | reported | 28 Apr 2014 | tx 5+1,064,648−4,648 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 3+450,000−453,038 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2026 | GRANT_AWARD | SpyGlass Pharma, Inc. | 17,500 | 0.00 USD | deriv |
| 05 Apr 2024 | TENDER | NGM BIOPHARMACEUTICALS INC | 3,038 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 450,000 | — | deriv |
| 01 Dec 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 450,000 | 0.00 USD | deriv |
| 01 Feb 2021 | EXERCISE | Coherus Oncology, Inc. | 7,402 | 10.05 USD | |
| 01 Feb 2021 | SALE | Coherus Oncology, Inc. | 7,402 | 21.55 USD | |
| 01 Feb 2021 | EXERCISE | Coherus Oncology, Inc. | 7,402 | 0.00 USD | deriv |
| 25 Jan 2021 | EXERCISE | Coherus Oncology, Inc. | 40,000 | 10.05 USD | |
| 25 Jan 2021 | SALE | Coherus Oncology, Inc. | 6,144 | 19.00 USD | |
| 25 Jan 2021 | SALE | Coherus Oncology, Inc. | 40,000 | 20.10 USD | |
| 25 Jan 2021 | EXERCISE | Coherus Oncology, Inc. | 40,000 | 0.00 USD | deriv |
| 11 Jan 2021 | GRANT_AWARD | Coherus Oncology, Inc. | 31,250 | 0.00 USD | |
| 11 Jan 2021 | GRANT_AWARD | Coherus Oncology, Inc. | 62,500 | 0.00 USD | deriv |
| 10 Jan 2021 | TAX_WITHHOLDING | Coherus Oncology, Inc. | 4,080 | 18.18 USD | |
| 17 Nov 2020 | SALE | Coherus Oncology, Inc. | 1,995 | 17.49 USD | |
| 17 Nov 2020 | EXERCISE | Coherus Oncology, Inc. | 1,500 | 13.50 USD | |
| 17 Nov 2020 | EXERCISE | Coherus Oncology, Inc. | 1,500 | 0.00 USD | deriv |
| 14 Oct 2020 | SALE | Coherus Oncology, Inc. | 6,144 | 19.00 USD | |
| 20 May 2020 | SALE | Coherus Oncology, Inc. | 1,278 | 17.66 USD | |
| 19 Feb 2020 | EXERCISE | Coherus Oncology, Inc. | 3,159 | 10.05 USD | |
| 19 Feb 2020 | SALE | Coherus Oncology, Inc. | 3,159 | 22.33 USD | |
| 19 Feb 2020 | EXERCISE | Coherus Oncology, Inc. | 3,159 | 0.00 USD | deriv |
| 15 Jan 2020 | SALE | Coherus Oncology, Inc. | 2,798 | 20.08 USD | |
| 15 Jan 2020 | EXERCISE | Coherus Oncology, Inc. | 6,318 | 10.05 USD | |
| 15 Jan 2020 | SALE | Coherus Oncology, Inc. | 3,520 | 19.67 USD |